Vertex Pharmaceuticals Defined Contribution Plan Cost remained flat by 0.0% to $15.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $13.08M to $15.78M. Over 2 years (FY 2023 to FY 2025), Defined Contribution Plan Cost shows an upward trend with a 20.3% CAGR.
An increase may reflect higher headcount, increased matching percentages, or rising salary bases, while a decrease could indicate cost-cutting or plan changes.
The total expense recognized by the company for contributions made to employee defined contribution retirement plans, su...
Standard personnel expense; peers report this under SG&A or operating expenses.
cat_defined_contribution_plan_cost| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $43.60M | $52.30M | $63.10M |
| YoY Change | — | +20.0% | +20.7% |